Trexquant Investment’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.92M	Buy	+67,361	New	+$3.1M	0.03%	753
2025 Q1	–	Sell	-11,397	Closed	-$447K	–	1912
2024 Q4	$447K	Sell	11,397 -5,510	-33%	-$228K	0.01%	1314
2024 Q3	$666K	Sell	16,907 -23,940	-59%	-$965K	0.01%	1180
2024 Q2	$1.59M	Sell	40,847 -6,027	-13%	-$241K	0.02%	828
2024 Q1	$2.02M	Buy	+46,874	New	+$2.16M	0.04%	647
2023 Q3	–	Sell	-7,446	Closed	-$287K	–	1882
2023 Q2	$287K	Buy	+7,446	New	+$296K	0.01%	1212
2021 Q4	–	Sell	-23,213	Closed	-$355K	–	1668
2021 Q3	$355K	Buy	+23,213	New	+$403K	0.03%	670
2020 Q2	–	Sell	-31,793	Closed	-$361K	–	1538
2020 Q1	$361K	Buy	+31,793	New	+$453K	0.03%	781
2019 Q1	–	Sell	-30,810	Closed	-$194K	–	1361
2018 Q4	$194K	Buy	30,810 +19,612	+175%	+$174K	0.01%	922
2018 Q3	$148K	Buy	+11,198	New	+$130K	0.01%	866